CorDx

CorDx is a biotechnology company that specializes in developing, manufacturing, and distributing in vitro diagnostic (IVD) medical device solutions. Founded in 2006, the company has over 2,100 employees and operates globally, serving healthcare industries and more than a billion users. CorDx focuses on rapid testing and diagnostic products that help users monitor and improve their health, addressing infectious diseases, chronic conditions, and personal health monitoring. The company offers end-to-end diagnostics development, including product design and regulatory expertise. CorDx provides flexible contract manufacturing solutions for point-of-care and over-the-counter rapid diagnostic products. Their integrated supply chain ensures quality control and competitive pricing, enhancing product availability worldwide. CorDx's product portfolio includes COVID-19 tests, influenza tests, multiplex rapid test kits, and various home-use and clinical care rapid test kits for fertility, drug, and heart health. The company collaborates with healthcare providers, consumers, and other organizations to improve patient outcomes and healthcare delivery globally.